Free Trial
NASDAQ:GMTX

Gemini Therapeutics (GMTX) Stock Price, News & Analysis

Gemini Therapeutics logo
$59.75 +1.03 (+1.75%)
As of 08/21/2025

About Gemini Therapeutics Stock (NASDAQ:GMTX)

Key Stats

Today's Range
$57.99
$60.27
50-Day Range
$50.05
$61.10
52-Week Range
$1.16
$14.10
Volume
216,520 shs
Average Volume
189,291 shs
Market Capitalization
$2.59 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GMTX Stock News Headlines

US attacks China, September 30?
The White House just ordered more than 400 government agencies to prepare for the next phase of America’s economic war with China. But this time, it’s not about tariffs or tech bans—it’s a sweeping master plan designed to make the U.S. $50 trillion richer at China’s expense. Treasury, Social Security, the Pentagon, and even the IRS are scrambling to meet the September 30 deadline. One expert says it could be the biggest economic development since the invention of the atomic bomb—and it could send trillions flowing into Americans’ pockets.tc pixel
See More Headlines

GMTX Stock Analysis - Frequently Asked Questions

Gemini Therapeutics' stock was trading at $63.40 on January 1st, 2025. Since then, GMTX shares have decreased by 7.4% and is now trading at $58.72.

Gemini Therapeutics, Inc. (NASDAQ:GMTX) issued its earnings results on Monday, November, 15th. The company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.04.

Shares of GMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gemini Therapeutics investors own include Alphabet (GOOG), Meta Platforms (META), NVIDIA (NVDA), Zoom Communications (ZM), Activision Blizzard (ATVI), Fiverr International (FVRR) and Shopify (SHOP).

Company Calendar

Last Earnings
11/15/2021
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GMTX
CIK
1816736
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$71.87 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-38.78%
Return on Assets
-35.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
71.49
Quick Ratio
71.49

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
20.32

Miscellaneous

Outstanding Shares
43,328,000
Free Float
37,739,000
Market Cap
$2.54 billion
Optionable
Not Optionable
Beta
-0.12
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:GMTX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners